Amundi Has $58,000 Position in Janux Therapeutics, Inc. (NASDAQ:JANX)
Amundi lowered its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) by 86.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,133 shares of the company’s stock after selling 7,238 shares during the quarter. Amundi’s holdings in Janux Therapeutics were worth […]
